A federal work group says Covid vaccine injuries deserve urgent attention, even as Health Secretary Robert F. Kennedy Jr.
The US Centers for Disease Control and Prevention’s vaccine advisory committee has postponed a decision regarding future recommendations for mRNA COVID-19 vaccines, opting to continue evaluating data ...
COVID-19 vaccine recommendations could be changing, according to the U.S. Food and Drug Administration. FDA leaders said on May 20 that clinical trials will be required to approve annual COVID-19 ...
COVID-19 cases remained relatively steady week-over-week in late August, though data from states showed "very high" viral activity at the end of the month, according to the Centers for Disease Control ...
A new COVID-19 variant sweeping through China has yet to make a sizable footprint in the U.S., the Centers for Disease Control and Prevention (CDC) says. In January, a new COVID-19 variant known as NB ...
As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well. It had one of its worst effectiveness rates in more than a decade.
A group of experts that advises the US Centers for Disease Control and Prevention on its vaccine recommendations has suspended an anticipated push to stop recommending mRNA-based Covid-19 vaccines ...
Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are ...
Advisers to RFK Jr drop the plan to end federal guidance amid Republican worries about the political impact ...
A U.S. federal vaccine advisory panel has changed its earlier position on COVID mRNA vaccines, discontinuing a push against them. The decision aligns with scientific evidence, despite opposition from ...
Some members of the CDC’s vaccine advisory panel have publicly questioned the safety and manufacturing of the shots, including raising a debunked theory that DNA contaminants in the vaccines are ...
Prasad angered pharmaceutical giants and lawmakers last month when he pulled the review process from Moderna’s new mRNA flu vaccine.